Terms: = Ovarian cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL
79 results:
1. Prevalence of BRCA1 and BRCA2 Mutations Among High-risk Bahraini Patients with Breast cancer.
Bukamal Z; AlRayes A
Gulf J Oncolog; 2023 May; 1(42):22-25. PubMed ID: 37283256
[TBL] [Abstract] [Full Text] [Related]
2. Estimation of Oncologic Surgery Case Volume Before and After the COVID-19 Pandemic in France.
Le Bihan-Benjamin C; Rocchi M; Putton M; Méric JB; Bousquet PJ
JAMA Netw Open; 2023 Jan; 6(1):e2253204. PubMed ID: 36701152
[TBL] [Abstract] [Full Text] [Related]
3. IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients.
Esmaeilian Y; Hela F; Bildik G; Akin N; İltumur E; Yusufoglu S; Yildiz CS; Keles İ; Vatansever D; Taskiran C; Yakin K; Oktem O
Hum Reprod; 2023 Jan; 38(1):113-124. PubMed ID: 36367834
[TBL] [Abstract] [Full Text] [Related]
4. Collection of cancer Patient Reported Outcome Measures (PROMS) to link with primary and secondary electronic care records to understand and improve long term cancer outcomes: A protocol paper.
Stamp E; Clarke G; Wright P; Velikova G; Crossfield SSR; Zucker K; McInerney C; Bojke C; Martin A; Baxter P; Woroncow B; Wilson D; Warrington L; Absolom K; Burke D; Stables GI; Mitra A; Hutson R; Glaser AW; Hall G
PLoS One; 2022; 17(4):e0266804. PubMed ID: 35427401
[TBL] [Abstract] [Full Text] [Related]
5. Better Agreement of Human Transcriptomic and Proteomic cancer Expression Data at the Molecular Pathway Activation Level.
Raevskiy M; Sorokin M; Zakharova G; Tkachev V; Borisov N; Kuzmin D; Kremenchutckaya K; Gudkov A; Kamashev D; Buzdin A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269755
[TBL] [Abstract] [Full Text] [Related]
6. The preventive effect of breastfeeding against ovarian cancer in BRCA1 and BRCA2 mutation carriers: A systematic review and meta-analysis.
Eoh KJ; Park EY; Chang YJ; Ha HI; Hong J; Huang D; Nam EJ; Lim MC
Gynecol Oncol; 2021 Oct; 163(1):142-147. PubMed ID: 34304906
[TBL] [Abstract] [Full Text] [Related]
7. Suppression of DNA Polymerase β Activity Is Synthetically Lethal in BRCA1-Deficient Cells.
Yuhas SC; Mishra A; DeWeese TL; Greenberg MM
ACS Chem Biol; 2021 Aug; 16(8):1339-1343. PubMed ID: 34240844
[TBL] [Abstract] [Full Text] [Related]
8. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
[TBL] [Abstract] [Full Text] [Related]
9. Feasibility of a large multi-center translational research project for newly diagnosed breast and ovarian cancer patients with affiliated biobank: the BRandO biology and outcome (BiO)-project.
De Gregorio A; Nagel G; Möller P; Rempen A; Schlicht E; Fritz S; Flock F; Kühn T; Thiel F; Felberbaum R; Ebner F; De Gregorio N; Friedl TWP; Wiesmüller L; Kuhn P; Schmitt M; Janni W; Rothenbacher D; Huober J
Arch Gynecol Obstet; 2020 Jan; 301(1):273-281. PubMed ID: 31781887
[TBL] [Abstract] [Full Text] [Related]
10. Hematological toxicities associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Wong EYT; Tan GHC; Kumar M; Teo MCC
Asia Pac J Clin Oncol; 2020 Apr; 16(2):e38-e46. PubMed ID: 31693307
[TBL] [Abstract] [Full Text] [Related]
11. The association of birthweight with age at natural menopause: a population study of women in Norway.
Bjelland EK; Gran JM; Hofvind S; Eskild A
Int J Epidemiol; 2020 Apr; 49(2):528-536. PubMed ID: 31633179
[TBL] [Abstract] [Full Text] [Related]
12. Dual-drug loaded micelle for combinatorial therapy targeting HIF and mTOR signaling pathways for ovarian cancer treatment.
Doddapaneni BS; Al-Fatease AM; Rao DA; Alani AWG
J Control Release; 2019 Aug; 307():272-281. PubMed ID: 31260753
[TBL] [Abstract] [Full Text] [Related]
13. Invasive Ductal Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas: A Case Report.
Sawai H; Kurimoto M; Koide S; Kiriyama Y; Haba S; Matsuo Y; Morimoto M; Koide H; Kamiya A; Yamao K
Am J Case Rep; 2019 Feb; 20():242-247. PubMed ID: 30798329
[TBL] [Abstract] [Full Text] [Related]
14. Characterization of ovarian cancer cells and tissues by Fourier transform infrared spectroscopy.
Li L; Bi X; Sun H; Liu S; Yu M; Zhang Y; Weng S; Yang L; Bao Y; Wu J; Xu Y; Shen K
J Ovarian Res; 2018 Aug; 11(1):64. PubMed ID: 30071867
[TBL] [Abstract] [Full Text] [Related]
15. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
[TBL] [Abstract] [Full Text] [Related]
16. Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining.
Li XJ; Pang JS; Li YM; Ahmed FA; He RQ; Ma J; Ma FC; Chen G
Pathol Res Pract; 2018 Mar; 214(3):385-401. PubMed ID: 29499854
[TBL] [Abstract] [Full Text] [Related]
17. Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood cancer Survivor Study.
Levine JM; Whitton JA; Ginsberg JP; Green DM; Leisenring WM; Stovall M; Robison LL; Armstrong GT; Sklar CA
Cancer; 2018 Mar; 124(5):1044-1052. PubMed ID: 29338081
[TBL] [Abstract] [Full Text] [Related]
18. Pathology update to the Manchester Scoring System based on testing in over 4000 families.
Evans DG; Harkness EF; Plaskocinska I; Wallace AJ; Clancy T; Woodward ER; Howell TA; Tischkowitz M; Lalloo F
J Med Genet; 2017 Oct; 54(10):674-681. PubMed ID: 28490612
[TBL] [Abstract] [Full Text] [Related]
19. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
20. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery.
Eoh KJ; Lee JY; Yoon JW; Nam EJ; Kim S; Kim SW; Kim YT
Oncotarget; 2017 Jun; 8(23):37807-37816. PubMed ID: 27906676
[TBL] [Abstract] [Full Text] [Related]
[Next]
